# Rare Disease Drug Repurposing AI

ğŸ§¬ Accelerated Drug Repurposing for Rare Diseases

## Mission & Top Priority

Accelerated Drug Repurposing for Rare Diseases is the top priority. It is profoundly humanityâ€‘saving: rare diseases often lack funding and timely treatment options, leading to avoidable mortality. This project focuses on rapidly identifying promising repurposing candidates among already FDAâ€‘approved drugs and presenting transparent, fully cited evidence to help clinicians and regulators assess viability faster. With LangChain tooling, we can prototype a workflow that queries structured biomedical data, retrieves literature, generates testable hypotheses, and outputs cited, reproducible reports suitable for clinical and regulatory review.

This repository contains a productionâ€‘minded, openâ€‘source foundation to: ingest structured/biomedical sources, run retrievalâ€‘augmented analysis, score/rank candidates, and generate auditable reports with claimâ€‘evidence traceability.

## Quick Start

### 1. Install uv (one-time)
```bash
curl -LsSf https://astral.sh/uv/install.sh | sh
```

### 2. Sync dependencies with uv
```bash
uv sync --dev
```

### 3. Start Backend
```bash
uv run python scripts/run_backend.py
```

### 4. Start Frontend (in new terminal)
```bash
uv run python scripts/run_frontend.py
```

### 5. Access the App
- **Frontend**: http://localhost:8501
- **Backend API**: http://localhost:8000
- **API Documentation**: http://localhost:8000/docs

## Demo Mode

The system runs in demo mode by default with:
- âœ… Mock data for diseases and drugs
- âœ… Realistic AI analysis results  
- âœ… No API keys required
- âœ… Fast local processing

## Features

- ğŸ”¬ **AI-Powered Analysis**: Drug repurposing with confidence scoring
- ğŸ“š **Citation Verification**: Every recommendation is source-verified
- ğŸ¨ **Modern UI**: Silicon Valley-style Streamlit interface
- ğŸš€ **FastAPI Backend**: High-performance async API
- ğŸ‹ **Docker Ready**: Full containerization support
- ğŸ§ª **Testing Suite**: Comprehensive test coverage

## What Weâ€™re Building First (MVP)

- Evidenceâ€‘grounded RAG pipeline for a single rare disease query
- Candidate drug ranking with transparent scoring and contraindication flags
- Autoâ€‘generated report: summary, rationale, and inline citations (PubMed/ClinicalTrials/etc.)
- Demonstration UI + REST API with downloadable, versioned report artifacts

## Architecture

```
Frontend (Streamlit) â†’ Backend (FastAPI) â†’ AI Agents â†’ Databases
     â†“                      â†“                â†“           â†“
  User Interface      REST API         LangChain    Vector DB
                                      Coordinator   Knowledge Graph
```

For detailed documentation, see the `docs/` directory:
- `docs/product-spec.md` â€” Product spec and requirements
- `docs/architecture.md` â€” Highâ€‘level system architecture
- `docs/system-architecture-rare-disease-drug-repurposing-ai.md` â€” Extended architecture
- `docs/api-specification-rare-disease-drug-repurposing-ai.md` â€” API specification

## Developer Notes

- Package management: use `uv` only (no pip). The project defines dependencies in `pyproject.toml` and a dev toolchain under `[tool.uv]`.
- Common commands:
  - `uv sync --dev` â€” create/update the `.venv` and install deps
  - `uv run pytest -q` â€” run tests
  - `uv run black .` â€” format code
  - `uv run flake8` â€” lint
  - `uv run mypy src` â€” type-check

## License

MIT License â€” see `LICENSE` for details.

If you use this project in research or clinical contexts, ensure compliance with local regulations. Outputs are decision support only and not medical advice.
